Boston Scientific inaugurates R&D centre in Pune

Boston Scientific Corporation has launched an R&D centre in Pune, its second in India, with the aim of capitalising on the country’s R&D expertise and providing diverse opportunities for engineers and innovators in the country.

The new facility was inaugurated by Dr Vinod K Paul, member (health), NITI Aayog, along with Art Butcher, Executive Vice President, and President, Boston Scientific APAC; Ralph Cardinal, Vice President R&D, Boston Scientific APAC; Sanjeev Pandya, Director R&D Boston Scientific India and Manoj Madhavan, Managing Director, Boston Scientific India.

The second India R&D centre in Pune will initially employ 170 engineers. It is spread across 45,000 square feet and equipped with medical equipment and simulators to further facilitate the R&D process and build more R&D capacity.

Speaking at the inauguration, Cardinal said, “Investing in R&D and clinical science is critical to the development of medical technologies and solutions that support patients around the world. Globally, Boston Scientific invests over $1 billion in R&D every year and we are pleased to further include India with the opening of this second R&D centre in Pune.”

The new R&D centre will provide expertise to all of the company’s therapy areas, namely interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, and urology and pelvic health. The R&D team in Pune will provide support in areas of mechanical design and analysis, software engineering, sustaining engineering, quality and compliance.

Pandya said, “This second R&D centre demonstrates Boston Scientific’s confidence in India’s R&D expertise and provides diverse opportunities for engineers and innovators in the country. It’s a key step in our journey as we address the needs of patients in India, the wider APAC region and around the world through innovation in India.”

Madhavan said, “Innovation is close to our hearts….. and we’re confident about the R&D talent in India. This second R&D centere reinforces our commitment to contribute meaningfully to the innovation landscape for medical devices in India.”